Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 4, 2006, Pages 798-810

  Kipper, Matt J ^a   Wilson, Jennifer H ^b   Wannemuehler, Michael J ^b   Narasimhan, Balaji ^a  

^a Iowa State University of Science and Technology   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Immune response mechanism; Microspheres; Polyanhydrides; Single dose vaccine; Tetanus toxoid

Indexed keywords

IMMUNE RESPONSE MECHANISM; POLYANHYDRIDES; SINGLE DOSE VACCINE; TETANUS TOXOID;

ANTIGENS; BIODEGRADABLE POLYMERS; COPOLYMERS; IMMUNOLOGY; MICROSPHERES; PROTEINS;

VACCINES;

1,6 BIS(4 CARBOXYPHENOXY)HEXANE; ADJUVANT; COPOLYMER; CYTOKINE; HEXANE; MICROSPHERE; POLYANHYDRIDE; SEBACIC ACID; TETANUS ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE; BIOMATERIAL;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; MALE; MEMORY CELL; MOUSE; NONHUMAN; PLASMA CELL; SINGLE DRUG DOSE; TH2 CELL; VACCINATION; ANIMAL; ANTIBODY AFFINITY; BIOREMEDIATION; C3H MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANIMALS; ANTIBODY AFFINITY; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C3H; MICROSPHERES; TETANUS TOXOID;

EID: 33644787333     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30545     Document Type: Article

References (53)

1. Grand challenges in global health. http://www.grandchallengesgh.org/. Accessed on June 24, 2004.
2. Aguado MT, Lambert P-H. Controlled-release vaccines - Biodegradable polylactide/polyglycolide(PL/PG) microspheres as antigen vehicles. Immunobiology 1992;184:113-125.
3. Levine MM. New Generation Vaccines. New York: Marcel Dekker; 1997.
4. Singh M, O'Hagan DT. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 2003;33:469-478.
5. 2- reactivity by the application of appropriate stimulatory antigens. Clin Exp Immunol 2003;134:78-85.
6. Guery JC, Galbiati F, Smiroldo S, Adorini L. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β(2)-microglobulin-deficient BALB/c mice. J Exp Med 1996;183:485-497.
7. Singh M, O'Hagan D. The preparation and characterization of polymeric antigen delivery systems for oral administration. Adv Drug Deliv Rev 1998;34:285-304.
8. Cleland JL. Single-administration vaccines: Controlled-release technology to mimic repeated immunizations. Trends Biotechnol 1999;17:25-29.
9. Langer R, Hanes J, Clelend JL. New advances in microsphere-based single-dose vaccines. Adv Drug Deliv Rev 1997;28:97-119.
10. Finkelman FD, Urban JF Jr. Cytokines: Making the right choice. Parasitol Today 1992;8:311-314.
11. McNeela EA, Mills KH. Manipulating the immune system: Humoral versus cell-mediated immunity. Adv Drug Deliv Rev 2001;51:43-54.
12. Woodland DL. Jump-starting the immune system: Prime-boosting comes of age. Trends Immunol 2004;25:98-104.
13. Gupta RK, Siber GR. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for TT. Biologicals 1994;22:53-63.
14. + T cell response induced by particulate antigen targeted to phagocytic cells. Int Immunol 1997;9:91-103.
15. Kipper MJ, Narasimhan B. Molecular description of erosion phenomena in biodegradable polymers. Macromolecles 2005;38:1989-1999.
16. Larobina D, Kipper MJ, Mensitieri G, Narasimhan B. Mechanistic understanding of degradation in bioerodible polymers for drug delivery. AIChE J 2002;48:2960-2970.
17. Shen E, Kipper MJ, Dziadul B, Lim M-K, Narasimhan B. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. J Control Release 2002;82:115-125.
18. Berkland C, Kipper MJ, Kim KK, Narasimhan B, Pack DW. Microsphere size, precipitation kinetics, and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release 2004;94:129-141.
19. Kipper MJ, Shen E, Determan A, Narasimhan B. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials 2002;23:4405-4412.
20. Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994;12:299-306.
21. Men Y, Thomasin C, Merkle HP, Gander B, Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 1995;13:683-689.
22. Schwendeman SP, Costantino HR, Gupta RK, Tobio M, Chang AC, Alonso MJ, Siber GR, Langer R. Strategies for stabilizing tetanus toxoid towards the development of a single-dose tetanus vaccine. In: Brown F, editor. New Approaches to Stabilization of Vaccines Potency. Basel: Karger; 1996. p 293-306.
23. Schwendeman SP, Costantino HR, Gupta RK, Siber GR, Klibanov AM, Langer R. Stabilization of tetanus and diphtheria toxoids against moisture induced aggregation. Proc Natl Acad Sci USA 1995;92:11234-11238.
24. Goepferich A, Langer R. The influence of microstructure and monomer properties on the erosion mechanism of a class of polyanhydrides. J Polym Sci Part A: Polym Chem 1993;31:2445-2458.
25. Mäder K, Nitschke S, Stosser R, Borchert H-H, Domb A. Non-destructive and localized assessment of acidic microenvironments inside biodegradable polyanhydrides by spectral spatial paramagnetic resonance imaging. Polymer 1997;38:4785-4794.
26. Determan AS, Trewyn B, Lin VSY, Nilsen-Hamilton M, Narasimhan B. Encapsulation, stabilization and release of BSA-FITC from polyanhydride microspheres. J Control Release 2004;100:97-109.
27. Conix A. Poly[1,3-bis(p-carboxyphenoxy)propane anhydride]. Macromol Synth 1966;2:95-98.
28. Kipper MJ, Seifert S, Thiyagarajan P, Narasimhan B. Understanding polyanhydride blend phase behavior using scattering, microscopy, and molecular simulations. Polymer 2004;45:3329-3340.
29. Shen E, Pizsczek R, Dziadul B, Narasimhan B. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials 2001;22:201-210.
30. Esparza I, Kissel T. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992;10:714-720.
31. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Meth 1986;86:83-87.
32. Narasimhan B, Kipper MJ. Surface-erodible biomaterials for drug delivery. Adv Chem Eng 2004;29:169-218.
33. Warren HS, Vogel FR, Chedid LA. Current status of immunological adjuvants. Annu Rev Immunol 1986;4:369-388.
34. Rimaniol AC, Gras G, Verdier F, Capel F, Grigoriev VB, Porcheray F, Sauzeat E, Fournier JG, Clayette P, Siegrist CA, Dormont D. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 2004;22:3127-3135.
35. Katti DS, Lakshmi S, Langer R, Laurencin CT. Toxicity, biodegradation, and elimination of polyanhydrides. Adv Drug Deliv Rev 2002;54:933-961.
36. Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H. Brain biocompatibility of a biodegradable controlled release polymer in rats. J Biomed Mater Res 1989;23:253-266.
37. Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R. Poly(anhydride) administration in high doses in vivo: Studies of biocompatibility and toxicology. J Biomed Mater Res 1990;24:1463-1481.
38. Brem H, Domb A, Lenartz D, Dureza C, Olivi A, Epstein JI. Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid. J Control Release 1992;19:325-329.
39. Brem H, Kader A, Epstein JI, Tamargo RJ, Domb A, Langer R, Leong KW. Biocompatibility of a biodegradable controlled-release polymer in the rabbit brain. Sel Cancer Ther 1989;5:55-65.
40. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: Missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352-363.
41. Kim DS, Drake-Lee AB. Infection, allergy and the hygiene hypothesis: Historical perspective. J Laryngol Otol 2003;117:946-950.
42. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-4853.
43. Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol 2002;14:523-536.
44. Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, Colombo MP, Steinman RM, Randolph GJ, Rescigno M. Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J Exp Med 2003;198:1253-1263.
45. Seong S-Y, Metzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-478.
46. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
47. Van der Kleij D, Yazdanbakhsh M. Control of inflammatory diseases by pathogens: Lipids and the immune system. Eur J Immunol 2003;33:2953-2963.
48. Hunter R, Strickland F, Kezdy F. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophilelipophile balance. J Immunol 1981;127:1244-1250.
49. Janeway CA, Travers P, Walport M, Shlomchik M. Immunobiology: The Immune System in Health and Disease. New York: Garland Publishing; 2001.
50. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003;71:1755-1762.
51. Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G Jr, Yang J, Lempicki RA, Sereti I, Lane HC. Cutting edge: L-Selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen. J Immunol 2003;170:28-32.
52. Lavigne MV, Castro M, Andino J, Manghi M. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response. Microbes Infect 2004;6:481-484.
53. Walker KB, Xing DK, Sesardic D, Corbel MJ. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres. Dev Biol Stand 1998;92:259-267.